Efficacy and Safety Evaluation for the Treatment of HDM Induced Allergic Asthma and Rhinitis/Rhinoconjunctivitis
Clinical trial NCT05400811 · UNKNOWN
Trial details
- NCT number
- NCT05400811
- Sponsor
- Inmunotek S.L.
- Status
- UNKNOWN
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2022-12-01
- Primary completion
- 2024-07-01
- Enrollment
- 400
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.